- Home
- SRFM vs RNAC Comparison
SRFM vs RNAC Comparison
Compare SRFM & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRFM | RNAC |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.7M | 175.8M |
| IPO Year | 2023 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SRFM | RNAC |
|---|---|---|
| Price | $3.05 | $7.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $5.81 | ★ $38.40 |
| AVG Volume (30 Days) | ★ 4.6M | 241.4K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $108,158,000.00 | $1,091,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.40 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.77 | $5.98 |
| 52 Week High | $9.91 | $20.12 |
Technical Indicators
Market Signals| Indicator | SRFM | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 67.73 | 55.03 |
| Support Level | $1.88 | $6.48 |
| Resistance Level | $3.14 | $7.31 |
| Average True Range (ATR) | 0.21 | 0.53 |
| MACD | 0.17 | 0.06 |
| Stochastic Oscillator | 89.49 | 66.84 |
Price Performance
Historical ComparisonAbout SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.